Surgery better than watchful waiting for younger prostate cancer patients
3/06/2014
A new study in the New England Journal of Medicine finds that mortality rates are lower for younger men having surgery for prostate cancer, compared with those who follow watchful waiting.Prostate cancer is common among older men and rare in men under the age of 40.
Nivolumab produces lasting remissions in melanoma patients
3/06/2014
A drug that unleashes the immune system to attack cancer can produce lasting remissions and hold the disease in check- for more than two years, in some cases - in many patients with advanced melanoma, according to a new study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions.
Local hyperthermia of tumors looks promising
3/06/2014
A combination of iron-oxide nanoparticles and an alternating magnetic field, which together generate heat, have activated an immune system response to tumors in mice according to an accepted manuscript by Dartmouth-Hitchcock Norris Cotton Center researchers in the journal Nanomedicine: Nanotechnology, Biology and Medicine released online.
Cancer drug divide between England and Wales
3/06/2014
Patients suffering from cancer in England are up to seven times more likely to be prescribed expensive cancer drugs than fellow sufferers in Wales, a new study assessing the impact of the Cancer Drugs Fund has revealed.
Nano systems tested to determine which works best in killing cancer cells
3/06/2014
New UC research to be presented this week tested four iron-oxide nanoparticle systems to see which, when heated, would likely work best as a tool for targeting cancer cells. In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.
Nivolumab produces lasting remissions in melanoma patients
3/06/2014
A drug that unleashes the immune system to attack cancer can produce lasting remissions and hold the disease in check- for more than two years, in some cases - in many patients with advanced melanoma, according to a new study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions.
Surgery better than watchful waiting for younger prostate cancer patients
3/06/2014
A new study in the New England Journal of Medicine finds that mortality rates are lower for younger men having surgery for prostate cancer, compared with those who follow watchful waiting.Prostate cancer is common among older men and rare in men under the age of 40.
Local hyperthermia of tumors looks promising
3/06/2014
A combination of iron-oxide nanoparticles and an alternating magnetic field, which together generate heat, have activated an immune system response to tumors in mice according to an accepted manuscript by Dartmouth-Hitchcock Norris Cotton Center researchers in the journal Nanomedicine: Nanotechnology, Biology and Medicine released online.
Cancer drug divide between England and Wales
3/06/2014
Patients suffering from cancer in England are up to seven times more likely to be prescribed expensive cancer drugs than fellow sufferers in Wales, a new study assessing the impact of the Cancer Drugs Fund has revealed.
Nano systems tested to determine which works best in killing cancer cells
3/06/2014
New UC research to be presented this week tested four iron-oxide nanoparticle systems to see which, when heated, would likely work best as a tool for targeting cancer cells. In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.